What Is a Brand-Name Drug
A brand-name drug is a medication marketed under the manufacturer's trademarked name. The pharmaceutical company that developed it holds the patent, giving them exclusive rights to manufacture and sell that formulation. Once the patent expires (typically 20 years from filing), generic versions can enter the market at substantially lower prices.
Why It Matters for Your Claims
Insurance companies place brand-name drugs on higher tiers on their formularies, which means your copay or coinsurance is significantly higher than for generic drugs. The cost difference is real: a month of brand-name medication can cost $200 to $500 out of pocket, while the generic equivalent might be $15 to $40.
When your claim is denied, the denial letter often states that a lower-cost generic or non-formulary alternative is available. This is where you need leverage. Your insurer may require prior authorization before covering a brand-name drug, or they may deny coverage outright unless you can demonstrate medical necessity. Your state's insurance regulations protect your right to appeal, and having clear documentation of why the brand-name version is medically necessary strengthens your internal or external appeal.
How Insurance Companies Handle Brand-Name Drugs
- Prior authorization requirement: Many insurers require your doctor to submit clinical justification before approving a brand-name drug. This typically takes 3 to 5 business days.
- Step therapy: Your insurer may require you to try the generic or cheaper alternative first, document that it failed or caused adverse effects, then resubmit for the brand-name version.
- EOB documentation: Your Explanation of Benefits will show the brand-name drug as "not covered" or "requires prior authorization." Keep this document for your appeal file.
- Formulary placement: Brand-name drugs sit on Tier 3 or Tier 4 of most formularies, meaning 30-50% coinsurance instead of a fixed copay.
Appealing a Brand-Name Drug Denial
If your insurer denies coverage for a brand-name drug, file an internal appeal within 30 days (or 180 days in some states). Your appeal letter should include:
- A statement from your prescribing physician explaining why the generic or alternative is ineffective, contraindicated, or causes intolerable side effects for your specific condition.
- Clinical evidence or published guidelines supporting the medical necessity of the brand-name formulation.
- Documentation of any prior attempts with generic versions (lab results, clinical notes, dates).
- A copy of the initial denial letter and your EOB.
If the internal appeal is denied, you have the right to request an external appeal through your state's insurance commissioner's office. State regulations vary, but most give you 30 to 60 days to file. External appeals are reviewed by an independent third party and have a higher reversal rate than internal appeals.
Common Questions
- Can my doctor just write "DAW" on the prescription? DAW stands for "Dispense as Written," which tells the pharmacy not to substitute a generic. However, your insurance company still needs to approve payment. DAW on the prescription alone does not override your insurer's formulary rules. Your doctor must also submit a prior authorization request with medical justification.
- What if the generic version is discontinued? If the generic form is no longer manufactured, that strengthens your appeal significantly. Include documentation from your pharmacy or the FDA's drug discontinuation database showing the generic is unavailable. Most insurers will cover the brand-name version in this scenario without requiring prior authorization.
- Does my state have any protections for expensive drugs? Yes. Most states have "any willing provider" laws and mental health parity rules that can apply to certain medications. Contact your state's insurance commissioner's office to learn what applies to your specific situation.